Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The purpose of the study is to compare the single dose PK of casdatifan between participants with moderate hepatic impairment (HI) and healthy matched control participants with normal hepatic function.
Epistemonikos ID: 5f99fda9c969dffe85b7e9ad9fd82295091a22bb
First added on: Aug 08, 2026